Source Pathology Services and LDPath have joined forces for market leading end to end cellular and digital pathology services. The two market leaders will become the biggest players with end-to-end offerings for pathology services, with a focus on digital pathology and AI.
The combined Source LDPath pathology workflow, with its market-leading digital and AI pathology services and link to further in-house precision medicine tests, provides a complete patient journey from first consultant contact to diagnosis.
For more information on all of our services download here.
